CIK 0001662579 · Non-accelerated filer<br>Smaller reporting company
C4 Therapeutics, Inc.
Sign in to watch- Ticker
- CCCC
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 475617627
- Phone
- (617) 231-0700
- Business address
- 490 ARSENAL WAY, SUITE 120, WATERTOWN, MA, 02472
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-02-14 | Siegel Jolie Chief Legal Officer | Grant or award · Stock Option (Right to Buy) | +84,700 | 84,700 | ||
| 2025-02-14 | Boyle Scott N Chief Business Officer | Grant or award 10b5-1 | +56,500 | 111,332 | ||
| 2025-02-14 | Boyle Scott N Chief Business Officer | Sale 10b5-1 | −490 | $3.15 | $2K | 110,842 |
| 2025-02-14 | Boyle Scott N Chief Business Officer | Shares withheld for taxes 10b5-1 | −2,368 | $3.18 | $8K | 108,474 |
| 2025-02-14 | Boyle Scott N Chief Business Officer | Grant or award · Stock Option (Right to Buy) 10b5-1 | +84,700 | 84,700 | ||
| 2025-02-14 | Mossler Mark Chief Accounting Officer | Shares withheld for taxes | −1,586 | $3.18 | $5K | 18,204 |
| 2025-02-14 | Schick Kelly Chief People Officer | Grant or award | +56,500 | 111,253 | ||
| 2025-02-14 | Schick Kelly Chief People Officer | Shares withheld for taxes | −2,368 | $3.18 | $8K | 108,885 |
| 2025-02-14 | Schick Kelly Chief People Officer | Grant or award · Stock Option (Right to Buy) | +84,700 | 84,700 | ||
| 2025-02-14 | Adams Kendra Chief Financial Officer | Grant or award | +87,100 | 169,676 | ||
| 2025-02-14 | Adams Kendra Chief Financial Officer | Shares withheld for taxes | −4,559 | $3.18 | $14K | 165,117 |
| 2025-02-14 | Adams Kendra Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +130,600 | 130,600 | ||
| 2025-02-14 | Mahaney Paige Chief Scientific Officer | Grant or award | +28,200 | 105,000 | ||
| 2025-02-14 | Mahaney Paige Chief Scientific Officer | Grant or award · Stock Option (Right to Buy) | +42,400 | 42,400 | ||
| 2025-02-14 | REYNO LEONARD Chief Medical Officer | Grant or award | +87,100 | 178,909 | ||
| 2025-02-14 | REYNO LEONARD Chief Medical Officer | Shares withheld for taxes | −5,145 | $3.18 | $16K | 173,764 |
| 2025-02-14 | REYNO LEONARD Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +130,600 | 130,600 | ||
| 2025-02-13 | Siegel Jolie Chief Legal Officer | Shares withheld for taxes | −2,135 | $3.20 | $7K | 54,353 |
| 2025-02-13 | Boyle Scott N Chief Business Officer | Shares withheld for taxes 10b5-1 | −1,735 | $3.20 | $6K | 54,832 |
| 2025-02-13 | Schick Kelly Chief People Officer | Shares withheld for taxes | −1,735 | $3.20 | $6K | 54,753 |
Page 5 of 27 · 525 trades